Publication Author: Sullivan_Sean
-
Review and meta-analysis of biomarkers and diagnostic imaging in Alzheimer’s disease.
Bloudek LM, Spackman DE, Blankenburg M, Sullivan SD. Review and meta-analysis of biomarkers and diagnostic imaging in Alzheimer’s disease. J Alzheimers Dis. 2011;26(4):627-45. doi: 10.3233/JAD-2011-110458. Review.
rakerr2
-
Cost-effectiveness of risk stratification for preventing type 2 diabetes using a multi-marker diabetes risk score.
Sullivan SD, Garrison LP Jr, Rinde H, Kolberg J, Moler EJ. Cost-effectiveness of risk stratification for preventing type 2 diabetes using a multi-marker diabetes risk score. J Med Econ. 2011;14(5):609-16. doi: 10.3111/13696998.2011.602160. Epub 2011 Jul 1
rakerr2
-
Effectiveness of biologic therapies for rheumatoid arthritis: an indirect comparisons approach.
Devine EB, Alfonso-Cristancho R, Sullivan SD. Effectiveness of biologic therapies for rheumatoid arthritis: an indirect comparisons approach. Pharmacotherapy. 2011 Jan;31(1):39-51.
rakerr2
-
Prescriber and staff perceptions of an electronic prescribing system in primary care: a qualitative assessment.
Devine EB, Williams EC, Martin DP, Sittig DF, Tarczy-Hornoch P, Payne TH, Sullivan SD. Prescriber and staff perceptions of an electronic prescribing system in primary care: a qualitative assessment. BMC Med Inform Decis Mak. 2010 Nov 19;10:72.
rakerr2
-
Dependence as a unifying construct in defining Alzheimer’s disease severity.
McLaughlin T, Feldman H, Fillit H, Sano M, Schmitt F, Aisen P, Leibman C, Mucha L, Ryan JM, Sullivan SD, Spackman DE, Neumann PJ, Cohen J, Stern Y. Dependence as a unifying construct in defining Alzheimer’s disease severity. Alzheimers Dement. 2010 Nov;6(
rakerr2
-
Cost analysis of interventions for antimuscarinic refractory patients with overactive bladder.
Watanabe JH, Campbell JD, Ravelo A, Chancellor MB, Kowalski J, Sullivan SD. Cost analysis of interventions for antimuscarinic refractory patients with overactive bladder. Urology. 2010 Oct;76(4):835-40.
rakerr2
-
Health technology assessment for resource allocation decisions: are key principles relevant for Latin America?
Pichon-Riviere A, Augustovski F, Rubinstein A, Martí SG, Sullivan SD, Drummond MF. Health technology assessment for resource allocation decisions: are key principles relevant for Latin America? Int J Technol Assess Health Care. 2010 Oct;26(4):421-7. Epub
rakerr2
-
Postoperative acquired coagulopathy: a pilot study to determine the impact on clinical and economic outcomes.
Devine EB, Chan LN, Babigumira J, Kao H, Drysdale T, Reilly D, Sullivan S. Postoperative acquired coagulopathy: a pilot study to determine the impact on clinical and economic outcomes. Pharmacotherapy. 2010 Oct;30(10):994-1003.
rakerr2
-
The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspective.
Campbell JD, Spackman DE, Sullivan SD. The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspective. Allergy. 2010 Sep;65(9):1141-8. Epub 2010 Feb 10.
rakerr2
-
Colony-stimulating factor prescribing patterns in patients receiving chemotherapy for cancer.
Ramsey SD, McCune JS, Blough DK, McDermott CL, Clarke L, Malin JL, Sullivan SD. Colony-stimulating factor prescribing patterns in patients receiving chemotherapy for cancer. Am J Manag Care. 2010 Sep;16(9):678-86.
rakerr2